Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 5
1988 3
1989 1
1990 2
1991 1
1992 1
1993 3
1994 4
1995 1
1997 2
1998 1
2000 3
2001 3
2003 4
2004 4
2005 3
2006 2
2007 4
2008 4
2009 2
2010 5
2011 5
2012 5
2013 1
2016 2
2017 1
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
Altered pain perception in schizophrenia.
Murakami H, Tamasawa N, Yamashita M, Takayasu S, Nigawara T, Matsui J, Suda T. Murakami H, et al. Among authors: tamasawa n. Lancet. 2010 Mar 6;375(9717):864. doi: 10.1016/S0140-6736(09)62061-4. Lancet. 2010. PMID: 20206779 No abstract available.
Regulation and roles of urocortins in the vascular system.
Kageyama K, Teui K, Tamasawa N, Suda T. Kageyama K, et al. Among authors: tamasawa n. Int J Endocrinol. 2012;2012:873723. doi: 10.1155/2012/873723. Epub 2012 May 13. Int J Endocrinol. 2012. PMID: 22654906 Free PMC article.
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
68 results